The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).
Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.
Deletion of ribosomal protein genes is a common vulnerability in human cancer, especially in concert with TP53 mutations.
2017-03-24 Skadade ribosomgener vanlig Akilleshäl i cancer Press release in Swedish.
Deletion of ribosomal protein genes is a common vulnerability in human cancer, especially in concert with TP53 mutations. Ram Ajore, David Raiser, Marie McConkey, Magnus Jöud, Bernd Boidol, Brenton Mar, Gordon Saksena, David M Weinstock, Scott Armstrong, Steven R Ellis, Benjamin L Ebert and Björn Nilsson. EMBO Mol Med. 2017 Apr; 9(4): 498–507.
